Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Neutropenia and ABCC2[original query] |
---|
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 2007 Jul 110 (1): 138-47. Han Ji-Youn, Lim Hyeong-Seok, Yoo Yeon-Kyeong, Shin Eun Soon, Park Yong Hoon, Lee Sung Young, Lee Jong-Eun, Lee Dea Ho, Kim Heung Tae, Lee Jin S |
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer science 2008 May 99 (5): 967-72. Kiyotani Kazuma, Mushiroda Taisei, Kubo Michiaki, Zembutsu Hitoshi, Sugiyama Yuichi, Nakamura Yusu |
Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2009 Jan 63 (1): 115-20. Han Ji-Youn, Lim Hyeong-Seok, Park Yong Hoon, Lee Sung Young, Lee Jin S |
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients. Cancer chemotherapy and pharmacology 2010 May 66 (1): 95-105. Sai Kimie, Saito Yoshiro, Maekawa Keiko, Kim Su-Ryang, Kaniwa Nahoko, Nishimaki-Mogami Tomoko, Sawada Jun-ichi, Shirao Kuniaki, Hamaguchi Tetsuya, Yamamoto Noboru, Kunitoh Hideo, Ohe Yuichiro, Yamada Yasuhide, Tamura Tomohide, Yoshida Teruhiko, Matsumura Yasuhiro, Ohtsu Atsushi, Saijo Nagahiro, Minami Hirono |
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients. Journal of human genetics 2009 Oct 54 (10): 564-71. Low Siew-Kee, Kiyotani Kazuma, Mushiroda Taisei, Daigo Yataro, Nakamura Yusuke, Zembutsu Hitos |
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jun 27 (16): 2604-14. Innocenti Federico, Kroetz Deanna L, Schuetz Erin, Dolan M Eileen, Ramírez Jacqueline, Relling Mary, Chen Peixian, Das Soma, Rosner Gary L, Ratain Mark |
Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010 May 29 (5): 509-16. Ohmann Erin L, Burckart Gilbert J, Brooks Maria M, Chen Yan, Pravica Vera, Girnita Diana M, Zeevi Adriana, Webber Steven |
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The pharmacogenomics journal 2013 Oct 13 (5): 403-9. Cecchin E, D'Andrea M, Lonardi S, Zanusso C, Pella N, Errante D, De Mattia E, Polesel J, Innocenti F, Toffoli |
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenetics and genomics 2013 Jan 23 (1): 29-33. Lewis Lionel D, Miller Antonius A, Owzar Kouros, Bies Robert R, Markova Svetlana, Jiang Chen, Kroetz Deanna L, Egorin Merrill J, McLeod Howard L, Ratain Mark J, |
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. Cancer chemotherapy and pharmacology 2012 May 69 (5): 1221-7. Kim Kyu-pyo, Ahn Jin-Hee, Kim Sung-Bae, Jung Kyung Hae, Yoon Dok Hyun, Lee Jung Shin, Ahn Sei-Hy |
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer chemotherapy and pharmacology 2013 Jan . Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, Kang GH, Jeong SY, Park KJ, Park JG, Kim TY |
Kinetic Interpretation of the Importance of OATP1B3 and MRP2 in Docetaxel-Induced Hematopoietic Toxicity. CPT: pharmacometrics & systems pharmacology 2014 3 e126. Yamada A, Maeda K, Kiyotani K, Mushiroda T, Nakamura Y, Sugiyama |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2014 Aug 24 (8): 387-96. Zgheib Nathalie K, Akra-Ismail Maya, Aridi Carol, Mahfouz Rami, Abboud Miguel R, Solh Hassan, Muwakkit Samar |
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Pharmacogenetics and genomics 2015 Sep . Chen Sylvia, Villeneuve Lyne, Jonker Derek, Couture Félix, Laverdière Isabelle, Cecchin Erica, Innocenti Federico, Toffoli Giuseppe, Lévesque Eric, Guillemette Chant |
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast cancer research and treatment 2015 Jul 152 (1): 67-76. Vulsteke Christof, Pfeil Alena M, Maggen Charlotte, Schwenkglenks Matthias, Pettengell Ruth, Szucs Thomas D, Lambrechts Diether, Dieudonné Anne-Sophie, Hatse Sigrid, Neven Patrick, Paridaens Robert, Wildiers Ha |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. British journal of cancer 2015 Mar 112 (5): 857-65. Teft W A, Welch S, Lenehan J, Parfitt J, Choi Y-H, Winquist E, Kim R |
Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort. BMC cancer 2019 Mar 19 (1): 246. Sone Kazuki, Oguri Tetsuya, Uemura Takehiro, Takeuchi Akira, Fukuda Satoshi, Takakuwa Osamu, Maeno Ken, Fukumitsu Kensuke, Kanemitsu Yoshihiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Niimi Ak |
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. Cancer chemotherapy and pharmacology 2020 Aug . Nomura Hisanaga, Tsuji Daiki, Demachi Ken, Mochizuki Nobuo, Matsuzawa Haruki, Yano Tomonori, Daiko Hiroyuki, Fujii Satoshi, Kojima Takashi, Itoh Kunihiko, Kawasaki Toshikat |
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis. Clinical and translational science 2022 May . Atasilp Chalirmporn, Biswas Mohitosh, Jinda Pimonpan, Nuntharadthanaphong Nutthan, Rachanakul Jiratha, Hongkaew Yaowaluck, Vanwong Natchaya, Saokaew Surasak, Sukasem Chonlaph |
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of personalized medicine 2022 4 12 (4): . Virgili Manrique Anna C, Salazar Juliana, Arranz María Jesús, Bagué Silvia, Orellana Ruth, López-Pousa Antonio, Cerdà Paula, Gracia Isidre, Majercakova Katarina, Peiró Ana, Trullols Laura, Fernández Manuel, Valverde Sandra, Quintana María Jesús, Bell Olga, Artigas-Baleri Alícia, Sebio A |
Predictive Value of ABCC2 and UGT1A1 Polymorphisms on Irinotecan-Related Toxicities in Patients with Cancer. Genetic testing and molecular biomarkers 2023 5 27 (5): 133-141. Zineb Aoullay, Andrew Smith, Meriem Slaoui, Ihssane El Bouchikhi, Hassan Ghazal, Najib Al Idrissi, Bouchra Meddah, Kara L Lynch, Yahia Cherrah, Alan H B |
Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia. Blood science (Baltimore, Md.) 2023 2 5 (1): 32-38. Hao Qishan, Song Yang, Fang Qiuyun, Lin Yani, Chen Long, Wang Xiaodan, Zhang Ping, Wang Zhe, Gong Xiaoyuan, Liu Kaiqi, Li Qinghua, Tian Zheng, Wang Min, Wang Jianxiang, Mi Yingcha |
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer. Cancer chemotherapy and pharmacology 2023 10 . Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: